Press Archives

CytoSorbents Receives Renewal of CytoSorb® CE Mark Through May 2024 and Annual ISO 13485:2016 Certification Through September 2022

Mr. Vincent Capponi, Chief Operating Officer of CytoSorbents stated, „I am happy to announce CytoSorbents successfully completed its CE Mark and ISO13485:2016 re-certification audits. These certificates cover CytoSorb and our new manufacturing facility commissioned in June 2018. The success of this renewal of the CE Mark and recent audit is a reflection of CytoSorbents‘ ongoing commitment to quality. I am very proud of our quality, manufacturing, and research teams that contributed to these accomplishments.“

CytoSorbents Expands CytoSorb Distribution in Latin America to Brazil, Colombia, and Costa Rica

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, expands CytoSorb distribution to Brazil, Colombia and Costa Rica, with Contatti Medical, Service & Medical Colombia, and Nutricare Costa Rica, respectively.

In Bramsche new procedure against blood poisoning

Blood poisoning is one of the leading causes of death in Germany. The Bramscher Niels Stensen clinics are now working as one of the first homes in the region with a new method that helps fight blood poisoning as early as possible and save human lives.

GPR Clinic introduces new procedure for sepsis therapy

The Department of Anaesthesiology, Anesthesiological Intensive Care and Perioperative Pain Management under the direction of Privatdozent Dr. med. med. Gerd Albuszies, MBA in the GPR Clinic, is now using a new therapy method in the critical care unit of the GPR Clinic, which is used in a massive inflammatory reaction of the body (inflammatory cytokine release) in sepsis.

Diakoniewerk Halle: Sepsis – More than a blood poisoning

Every year, up to 20 million people worldwide die of sepsis. That’s up to 13% more than ten years ago. Today, more people are dying of sepsis than total prostate and breast cancer and HIV / AIDS combined.

Award for critical care physicians at the Emden Clinic

The therapy of severe blood poisoning – termed Sepsis – is one of the specialties of critical care at the Klinikum Emden. The Department of Anaesthesiology and Intensive Care Medicine under the direction of chief physician Dr. med. Klaus Kogelmann has long been represented at international congresses with his own work and together with the German working group SepNet (Competence Network Sepsis). For example, at the 7th International Sepsis Congress in Weimar in September, a presentation on the subject of “Blood purification in sepsis” (Cytosorb) was presented.